Cancer Metabolism

Can stromal-rich tumours rewire colon cancer metabolism to promote therapy resistance?

Queen's University Belfast

School of Medicine, Dentistry and Biomedical Sciences

Location
Belfast, United Kingdom
Funding
See university guidance
Application deadline
See university guidance

About the project

My research focuses on how cancer cells rewire their metabolism to survive therapy, progress and interact with the tumour microenvironment. Working across colorectal and lung cancer, my group investigates mechanisms of treatment resistance, including mitochondrial adaptation, nucleotide metabolism, sialylation, KRAS-driven metabolic rewiring and immunometabolic crosstalk. We integrate advanced pre-clinical models, organoids, in vivo systems, multi-omic, imaging and functional analyses to identify therapeutic vulnerabilities and biomarkers that could inform more effective, personalised cancer treatment.

  • Dr Emma Kerr: School of Medicine, Dentistry and Biomedical Sciences

Contact info

  • View Academic Profile
  • Emma.Kerr@qub.ac.uk
  • 02890972942

Research Interests

Our lab would suit projects focused on cancer metabolism, therapy resistance, translational oncology and tumour microenvironment biology.

Make a PhD enquiry

Current Research Opportunities

  • Can stromal-rich tumours rewire colon cancer metabolism to promote therapy resistance?

Discover More

  • Faculty of Medicine, Health and Life Sciences
  • School of Medicine, Dentistry and Biomedical Sciences
  • Johnston Cancer Research Centre

Research areas

Cancer MetabolismOncologyBiologyCancer

Related PhD opportunities